• Home
  • Onko Ilac Sanayi ve Ticaret A.S.

Onko Ilac Sanayi ve Ticaret A.S.

  • OnkoFactory
  • Facility B
  • Onko Kocsel Pharmaceuticals
About Onko Ilac Sanayi ve Ticaret A.S.

Onko Koçsel Pharmaceuticals has first taken its place in the pharmaceutical sector in 1987 by introducing blood derivative products in Turkey and becoming an exclusive distributor for the reputable European companies. It is primarily focused on oncology, hematology, rheumatology and radiology therapeutic areas.  
Onko&Kocsel’s state of art facility has high production capacities with worldwide standards in manufacturing and quality systems. The facility which is in operation since 2014 has TR GMP, EU GMP. Contact us via [email protected]

Read more Show less
Certifications
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • TR
  • 2015
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Frankfurt 2025

Messe Frankfurt
28 Oct 2025 - 30 Oct 2025
View Exhibitor Profile

Products from Onko Ilac Sanayi ve Ticaret A.S. (36)

  • Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml

    Product Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml

    Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information.
  • Bortezomib Onko (Bortezomib), 3.5 mg, Powder for solution for Injection-Vial

    Product Bortezomib Onko (Bortezomib), 3.5 mg, Powder for solution for Injection-Vial

    Bortezomib Onko (Bortezomib), 3.5 mg, is in Powder for solution for Injection-Vial form. Bortezomib is an antineoplastic agent which is used to treat people with multiple myeloma and  mantle cell  lymphoma. Contact us for more information.
  • Azatu (Azacitidine), 100 mg, Powder for Injection Suspension-Vial

    Product Azatu (Azacitidine), 100 mg, Powder for Injection Suspension-Vial

    Azacitidine,100 mg, Powder for Injection Suspension- Vial  is used to treat acute myelogenous leukemia, chronic myelogenous leukemia (CML), myelodysplastic syndrome. Contact us for more information.
  • Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml

    Product Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml

    Zomtu (Zoledronic Acid) Concentrated Solution for IV Infusion - Vial, 4 mg/5 ml, 4 mg/100 ml is used along with cancer chemotherapy to treat bone damage caused by multiple myeloma or by cancer that began in another part of the body but has spread to the bones. Please contact us for more information.
    ...
  • Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml)

    Product Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml)

    Kopaq (Iohexol), Concentrated Solution for Injection - Vial, 300 mgI/ml (50 ml), 300 mgI/ml (100 ml), 350 mgl/ml (50 ml), 350 mgl/ml (100 ml), 350 mgl/ml (200 ml) is a iodinated, nonionic, low osmolar contrast agent.The product is used in arthrography, endoscopic retrograde pancreatography (ERP), endoscopi...
  • Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion

    Product Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion

    Misintu (Mitomycin), 20 mg, Powder for Solution for Injection/Infusion is used to treat bladder cancer, breast cancer, head and neck cancer, stomach and pancreatic cancer, prostate cancer and cervical cancer. Contact us for more information.
  • Docetu (Docetaxel) 20 mg/ml, 80 mg/ml, 160 mg/8 ml

    Product Docetu (Docetaxel) 20 mg/ml, 80 mg/ml, 160 mg/8 ml

    Docetaxel is an antineoplastic agent. It is prepared by semisynthesis beginning with a precursor extracted from the renewable needle biomass of yew plants. Docetaxel is a white to almost-white powder with an empirical formula of C43H53NO14• 3H2O, and a molecular weight of 861.9. It...
  • Epiritu (Epirubicine HCL) 10 mg/5 ml, 200 mg/100 ml, 50 mg/25 ml

    Product Epiritu (Epirubicine HCL) 10 mg/5 ml, 200 mg/100 ml, 50 mg/25 ml

    Epiritu is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug.  This medication is classified as an "anthracyline antitumor antibiotic. Epiritu is used to treat breast cancer.  It is used as adjuvant therapy in women who have had surgery and have lymph node involvement.May be...
  • Azacitidine Injection 100mg/vial (Azacitidine)

    Product Azacitidine Injection 100mg/vial (Azacitidine)

    This medication is used to treat a group of blood/bone marrow disorders (myelodysplastic syndromes-MDS) in which the bone marrow does not produce enough healthy blood cells
  • Bortezomib Injection 3.5 mg vial (Bortezomib)

    Product Bortezomib Injection 3.5 mg vial (Bortezomib)

    It is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma
  • Doxtu (Doxorubicine HCL) 10 mg/5 ml, 50 mg/25 ml

    Product Doxtu (Doxorubicine HCL) 10 mg/5 ml, 50 mg/25 ml

    Doxtu is an anti-cancer (“antineoplastic” or “cytotoxic”) chemotherapy drug. Doxorubicin is classified as an “anthracycline antibiotic.” Doxtu is administered via an intravenous (IV) injection through a central line or a peripheral venous line, and the drug is given over several minutes. Contact us fo...
  • Gemtu (Gemcitabine HCL) 1000mg/10ml, 2000mg/20ml, 200mg/2ml

    Product Gemtu (Gemcitabine HCL) 1000mg/10ml, 2000mg/20ml, 200mg/2ml

    Gemtu (gemcitabine for injection) is a nucleoside metabolic inhibitor that exhibits antitumor activity. Gemcitabine HCl is 2´-deoxy-2´,2´-difluorocytidine monohydrochloride (β-isomer). Gemtu in combination with carboplatin is indicated for the treatment of patients with advanced ovarian cancer&nb...
show all 36 products

Onko Ilac Sanayi ve Ticaret A.S. Resources (3)